- Investing Ideas
- U.K. Pharmaceuticals & Biotech Profitable Climbers
U.K. Pharmaceuticals & Biotech Profitable Climbers
Results
2
0 new
2 companies
AstraZeneca
Market Cap: UK£225.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£145.36
7D
-1.6%
1Y
40.3%
Animalcare Group
Market Cap: UK£229.6m
Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.
ANCR
UK£3.33
7D
34.6%
1Y
44.6%